Institut Pasteur

Jacques Bellalou

Pierre Lafaye

Sylvie Van Der Werf

Nicolas Escriou

Stéphane Petres

Caroline Demeret

Robert A Longin

Emmanuel Frachon

Alain Meier

The invention relates to the diagnosis of a SARS-associated coronavirus, such as a SARS-CoV-2 infection and SARS-CoV-1 infection, using the N_SARS-CoV-1 and N_SARS-CoV-2 proteins and antibodies binding to these proteins. The invention reagents, methods and kits for the detection of a SARS-associated coronavirus.

Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics

The invention relates to the diagnosis of a SARS-associated coronavirus, such as a SARS CoV-2 infection and SARS-CoV infection, using the SARS-CoV and SARS-CoV-2 nucleocapsid proteins and antibodies binding to these proteins. The invention encompasses reagents, methods and kits for the detection of a SARS-associated coronavirus.

Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics

Severe acute respiratory syndrome (SARS)&#x2014;associated coronavirus diagnostics

An automated and robotized platform includes a battery of miniature reactors to contain cell cultures. The platform includes an external sensor to measure an optical property of each cell culture contained in each miniature reactor. The platform also includes a mobile sensor-holder to receive the external sensor. The sensor-holder includes a sensor driving element to move the external sensor from one miniature reactor to another and to measure in real time the at least one optical property. The platform further includes a controlling and processing element to receive real time measurements of the optical property from the external sensor and to provide real time control of a movement of the mobile sensor-holder.

Robotized platform for cell cultures in miniature reactor batteries, equipped with a system for real time measurement of cellular turbidity or other optical properties

Growing community of inventors

Paris, France

Jacques Bellalou